The @PyrlsApp makes drug information easy for 50,000+ clinicians and student clinicians 🔮 💊 | a @ycombinator company

Joined March 2021
Pinned Tweet
The 2026 GINA Report is here, with several notable updates to asthma management guidance:
1
1
11
1,475
Massive update to the Pyrls NAPLEX Virtual Testing Center. 1,000+ practice questions, a new Practice Mode, updated full mock exams, realistic timing, and more (see next tweet). Included for Pyrls Pro members + new NAPLEX-only option now available at pyrls.com.
2
6
1,447
What’s new: 1,000+ NAPLEX-style practice questions Practice Mode: • Build custom quizzes with 10–500 questions • Study by domain, topic, or missed questions • Choose timed or untimed sessions • Review explanations after every question Full Mock Exam: • 225 exam-weighted questions • 6-hour realistic simulation • Forward-only navigation • Detailed competency reports • Resume unfinished sessions Limited-time launch offer: Get 12 months of unlimited NAPLEX Prep for $50, regularly $100. Available now at pyrls.com.
2
4
465
FDA Approves UTEBZI (tebipenem pivoxil), the First Oral Carbapenem for Complicated UTI Treatment
1
4
826
FDA Approves Q8W Dosing Regimen for EBGLYSS (lebrikizumab-lbkz)
1
523
FDA Approves ZAYNICH (cefepime/zidebactam) for Complicated UTI Treatment
1
5
633
We released our new Dyslipidemia Pharmacotherapy Review, which includes recommendations from the 2026 ACC/AHA/Multisociety Guideline! ✨ Find the full review and pharmacotherapy chart in the Pyrls mobile app and at pyrls.com. 📱
1
1
9
804
New FDA approval! ✨ BAXFENDY (baxdrostat) is now approved for adults with hypertension not adequately controlled on other agents.
1
4
595
New FDA approval: TRIMBOW is now approved as another ICS/LABA/LAMA option for maintenance treatment of asthma in adults. ✨
1
1
7
969
Charts!!!
We’ve updated our insulin products chart to include Awiqli and Langlara for an at-a-glance comparison of insulin options. ✨ Find this full chart and more pharmacotherapy resources in the Pyrls mobile app and at pyrls.com. 📱
2
7
1,541
We’ve updated our insulin products chart to include Awiqli and Langlara for an at-a-glance comparison of insulin options. ✨ Find this full chart and more pharmacotherapy resources in the Pyrls mobile app and at pyrls.com. 📱
2
1
4
1,967
We will be attending the @PQAAlliance Annual Meeting next week in Baltimore! We’re looking forward to showing members how Pyrls is helping modernize drug information for teams across pharmacy, MTM, and healthcare quality. Stop by the Industry Showcase and say hi! #PQA26 #MTM
3
389
Our team is actively reviewing the new guidance and updating key Pyrls resources, including our Asthma Management chart, to reflect these changes. Stay tuned in the Pyrls app and at pyrls.com for updated clinical pearls and refreshed asthma tools. ✨
1
4
346
A lot of you follow Pyrls for drug news, charts, and pharmacy education. But many of you still do not know we have an app that’s free to download!
🤖 Made with AI
2
3
562
The Pyrls app includes: - Drug summaries - Drug interaction checker - Pharmacotherapy reviews - Pill identifier - Pill counter (yes the app can count pills!) - Clinical charts and tables - And more Built for pharmacy students, pharmacists, clinicians, and anyone who needs access to practical medication information. Available on iOS and Android! 📱
382
FDA Approves FOUNDAYO (orforglipron), an Oral GLP-1 Receptor Agonist, for Weight Loss
6
12
1,108
We’ve got a booth at @pharmacists APhA Annual! If you’re here, come say hi in the exhibit hall and get a free digital business card powered by @HelixCardApp. We’ll also have pharmacotherapy charts, and of course, pens! Hope to see you there! 💜
1
2
397
Zepbound (tirzepatide) Now Available in Multi-Dose KwikPen
8
142,917
FDA Approves BYSANTI (milsaperidone) for the Treatment of Schizophrenia and Bipolar I Disorder
1
5
619